Friday, March 8, 2019
Medical News Today: The FDA approve esketamine nasal spray for severe depression
Federal regulators have approved the use of the new prescription nasal spray drug esketamine for depression that has not responded to other treatments.
Related Posts:
Keep using sunscreen while FDA updates recommendations on safety of sunscreen ingredients- Medical News Today: 11 ways to increase bone density naturally
- The CBD Drink You Should Have Before A Big Speech
UK HealthCare again named best Ky. hospital in U.S. News & World Report rankings; Baptist Health has three of six on list- What’s the Deal with Food Sensitivity Test Kits?
0 comments:
Post a Comment